FEATURE ARTICLES
Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.
- Beyond API Sourcing: Avoiding Supply Disruptions For Small Molecule Drugs
- Why We Need Pharmaceutical Engineering Project Management As A Distinct Discipline
- Your 7 Decisions To Make Before MES Configuration
- The Orange Book's Blind Spot: Process Stability And Capability
- Are You Falling Behind On Intelligent Pharmaceutical Manufacturing?
- Qualification And Validation Of Depyrogenation Tunnels And Autoclaves
- DEA Reveals Hidden Costs Of Analytical Validation Guidelines
PHARMA ONLINE WHITE PAPERS
-
Biopharma Supply, Reimagined: Regional, Resilient Manufacturing
Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.
-
Smarter By The Second Redefining Pharma Biopharma Manufacturing6/2/2026
Continuous monitoring is transforming manufacturing. With advanced analytics and sensor technologies, teams can detect issues early and optimize processes in real time for greater efficiency.
-
The Importance Of Polymorph Screenings5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
The Problem With Construction Quality10/21/2024
Data center construction quality management is inadequate, with issues traced to human error. A stronger focus on quality control and assurance is needed for success.
-
The Importance Of Quality In Raw Material Selection1/16/2025
Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.
-
Achieve Higher Targeted Concentrations9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors
- Ultra-Low Cross-Linked Microgel Purification
- Reducing Cycle Time By 88% Through Strategic Solvent Replacement In Pharmaceutical Development
- Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis
- Analyzing Biological Drug Effects In 3D
NEWSLETTER ARCHIVE
- 10.21.26 -- Reduce risk. Move Annex 1 forward.
- 10.21.26 -- Packaging, Labeling, And Logistics Best Practices
- 10.21.26 -- Spray Drying Advances Are Expanding Options For Poorly Soluble Molecules
- 10.20.26 -- AI Innovation Is Transforming Drug Development And Manufacturing
- 10.20.26 -- Are You Falling Behind On Intelligent Pharmaceutical Manufacturing?
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
MVIC And Upperton Pharma Solutions Announce Strategic Collaboration10/20/2026
MVIC (Medicon Valley Inhalation Consortium) and Upperton Pharma Solutions today announced a strategic collaboration designed to provide pharmaceutical and biotech companies with a seamless, end-to-end solution spanning early discovery, formulation development, preclinical support, and clinical trial manufacturing.
-
Hapman To Unveil New Conveying Solution At PACK EXPO 202610/15/2026
Hapman, a global leader in custom built bulk material handling equipment, will exhibit at PACK EXPO 2026, taking place October 18–21, 2026, in Chicago, Illinois. Attendees are invited to visit Hapman at Booth LU-7258 to explore the Bulk Bag Filler, Helix® Flexible Screw Conveyor, Bulk Bag Unloader, and CablePro™ Tubular Drag Conveyor.
-
Pharmaceutical Online Covers Honorable Mention FOYA Award Winner, Chugai Pharmaceutical Co., Ltd.10/13/2026
Chugai Pharmaceutical Co., Ltd. is advancing pharmaceutical manufacturing through extensive automation at its FJ3 active pharmaceutical ingredient (API) production facility, a project that was recently recognized with a 2026 ISPE Facility of the Year Awards (FOYA) Honorable Mention.
-
Emerson Expands Life Sciences Scheduling Software To Optimize Quality Control Lab Testing10/13/2026
Global automation leader Emerson today announced an enhancement to its DeltaV™ Real-Time Scheduling (RTS) software that extends integrated, real-time manufacturing scheduling capabilities to quality control (QC) labs.
-
GSK Announces Drug Manufacturing Expansion In Pennsylvania10/13/2026
Today, Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the Commonwealth has secured an over $800 million investment from global biopharma company GSK to expand its operations in Montgomery County. The expansion will create more than 300 new jobs over the next five years, retain approximately 4,500 existing full-time jobs across the Commonwealth, and continue growing Pennsylvania’s robust life sciences industry.